Literature DB >> 9659169

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study.

P Karlén1, D Kornfeld, O Broström, R Löfberg, P G Persson, A Ekbom.   

Abstract

BACKGROUND: Colonoscopic surveillance is a standard procedure in many patients with long standing, extensive ulcerative colitis (UC), in order to avoid death from colorectal cancer. No conclusive proof of its benefits has been presented however. AIMS: To evaluate the association between colonoscopic surveillance and colorectal cancer mortality in patients with UC. PATIENTS: A population based, nested case control study comprising 142 patients with a definite UC diagnosis, derived from a study population of 4664 patients with UC, was conducted.
METHODS: Colonoscopic surveillance in all patients with UC who had died from colorectal cancer after 1975 was compared with that in controls matched for age, sex, extent, and duration of the disease. Information on colonoscopic surveillance was obtained from the medical records.
RESULTS: Two of 40 patients with UC and 18 of 102 controls had undergone at least one surveillance colonoscopy (relative risk (RR) 0.29, 95% confidence interval 0.06 to 1.31). Twelve controls but only one patient with UC had undergone two or more surveillance colonoscopies (RR 0.22, 95% confidence interval 0.03 to 1.74), indicating a protective dose response relation.
CONCLUSION: Colonoscopic surveillance may be associated with a decreased risk of death from colorectal cancer in patients with long standing UC.

Entities:  

Mesh:

Year:  1998        PMID: 9659169      PMCID: PMC1727094          DOI: 10.1136/gut.42.5.711

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Ulcerative colitis and colorectal cancer. A population-based study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

2.  Cancer risk and life expectancy of children with ulcerative colitis.

Authors:  G J Devroede; W F Taylor; W G Sauer; R J Jackman; G B Stickler
Journal:  N Engl J Med       Date:  1971-07-01       Impact factor: 91.245

3.  Colitic cancer: supervision, surveillance, or surgery?

Authors:  J E Lennard-Jones
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

4.  Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis.

Authors:  P Rozen; M Baratz; F Fefer; T Gilat
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

5.  Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.

Authors:  D Pinczowski; A Ekbom; J Baron; J Yuen; H O Adami
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

6.  Rectal biopsy as an aid to cancer control in ulcerative colitis.

Authors:  B C Morson; L S Pang
Journal:  Gut       Date:  1967-10       Impact factor: 23.059

Review 7.  Failure of colonoscopic surveillance in ulcerative colitis.

Authors:  D A Lynch; A J Lobo; G M Sobala; M F Dixon; A T Axon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

8.  Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis.

Authors:  D Provenzale; K V Kowdley; S Arora; J B Wong
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

9.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

Review 10.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

Authors:  C N Bernstein; F Shanahan; W M Weinstein
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

View more
  62 in total

Review 1.  Cancer surveillance in inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  1999-12

2.  Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Authors:  Laszlo Lakatos; Gabor Mester; Zsuzsanna Erdelyi; Mihaly Balogh; Istvan Szipocs; Gyorgy Kamaras; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

3.  Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

Authors:  J A Eaden; J F Mayberry
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

4.  Survival in elderly patients with ulcerative colitis and colorectal cancer.

Authors:  Wojciech Blonski; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

5.  Colitic cancer developed after introduction of azathioprine.

Authors:  Jun-ichi Sasaki; Yutaka J Kawamura; Fumio Konishi; Tsutomu Tosha
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 6.  The approach to dysplasia surveillance in inflammatory bowel disease.

Authors:  Remo Panaccione
Journal:  Can J Gastroenterol       Date:  2006-04       Impact factor: 3.522

Review 7.  Multi-target stool DNA test: a new high bar for noninvasive screening.

Authors:  David A Ahlquist
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

Review 8.  Management of inflammatory bowel disease.

Authors:  M Nayar; J M Rhodes
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

9.  Ulcerative colitis: the fate of the retained rectum.

Authors:  Adam Juviler; Neil Hyman
Journal:  Clin Colon Rectal Surg       Date:  2004-02

Review 10.  Endoscopic and pathological aspects of colitis-associated dysplasia.

Authors:  Fiona D M van Schaik; G Johan A Offerhaus; Marguerite E I Schipper; Peter D Siersema; Frank P Vleggaar; Bas Oldenburg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-22       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.